688553.SS · 汇宇制药
China A-shares · RS rating 10 · As of 2026-10-14
| Price | 11.01 CNY |
|---|---|
| 1-day change | -2.7% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 51 / 33 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 3 / 3 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.0% |
| Distance from 52-week high | +56.1% |
| Market cap (USD) | $1.1B |